AZILECT^® Information

AZILECT^® (rasagiline tablets) is the first once-daily treatment for people with Parkinson's disease.

A therapy that brings together efficacy and convenient dosing.

AZILECT^® is indicated for the treatment of the signs and symptoms of Parkinson’s disease (PD) both as initial therapy alone and to be added to levodopa later in the disease. The effectiveness of AZILECT^® was shown in patients with early PD who were receiving AZILECT^® as initial therapy alone and who were not receiving any other PD therapy. The effectiveness of AZILECT^® as adjunct therapy was shown in patients with PD who were treated with levodopa.

AZILECT^® is the first once-daily medication for the treatment of PD.

• One AZILECT^® pill per day helps relieve many of the troubling symptoms of PD.
• AZILECT^® may be taken alone or in combination with other PD medications.
• AZILECT^® therapy is well tolerated.

How AZILECT^® Works

Over time, PD will cause you to lose more and more dopamine in your brain.

AZILECT^® works by blocking the breakdown of dopamine in the brain. As much as 60% to 80% of dopamine could be lost by the time PD is diagnosed. With more dopamine available in your brain, you can move more freely again. Everyday tasks may become less difficult.

To find out more about AZILECT^® visit www.azilect.com.